• AAPL 172.63
  • TSLA 180.27
  • AMZN 184.64
  • MSFT 396.515
  • INTC 30.305
  • EURUSD 1.0725
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NEO /
  3. ABBV.NEO

AbbVie Inc. CDR (ABBV NEO) stock market data APIs

C$23.62 -0.03(-0.1%) as of May 1, 2024

AbbVie Inc. CDR Financial Data Overview

23.65
23.62
-
23.87
23.62
18.6874-26.4242
390 597 M
5.1721
1 771 M
54 403 M
0.0376
0.564
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ABBV',
Type: 'Common Stock',
Name: 'AbbVie Inc. CDR',
Exchange: 'NEO',
CurrencyCode: 'CAD',
CurrencyName: 'Canadian Dollar',
CurrencySymbol: 'C$',
CountryName: 'Canada',
CountryISO: 'CA',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - General',
}

AbbVie Inc. CDR Fundamental Data is available in our Financial Data APIs

  • Net Revenue 54 403 M
  • EBITDA 26 876 M
  • Earnings Per Share 4.59
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get AbbVie Inc. CDR Earnings via APIs

  • Latest Release 2024-05-03
  • EPS/Forecast NaN

Get AbbVie Inc. CDR End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get AbbVie Inc. CDR latest news via APIs

Top 25 Stocks in the S&P 500 by Index Weight Right Now

In this piece, we will take a look at the top 25 stocks in the S&P 500 by index weight right now. If you want to skip our coverage of the flagship stock index and some recent news for its biggest cons...

CVS stock plunges after earnings numbers one analyst 'did not even believe'

CVS (CVS) disappointed Wall Street Wednesday by missing revenue estimates and revising down its 2024 guidance, and expects to raise insurance plan prices in the coming year as it adjusts for Medicare ...
Do you have any questions?
support@eodhistoricaldata.com